Van N. Nguyen - Concepedia

Concepedia

Author

Van N. Nguyen

Bristol-Myers Squibb (United States)

Also Known As

Nguyen, Van N., V. N. NGUYEN, V.N. Nguyen, Van N Nguyen, Van N. Nguyen

27

Publications

1.5K

Citations

15

H-Index

19

Concepts

All Affiliations

Bristol-Myers Squibb (United States)Johnson & Johnson (United States)Bristol-Myers Squibb (Canada)

VN

About

Van N. Nguyen is an author at Bristol-Myers Squibb (United States) specializing in drug discovery, medicine, and pharmacology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	10	10	1.3K
2	Natural Sciences	4	4	128
3	Biochemistry	4	4	142
4	Biomolecular Engineering	3	3	73
5	Chemical Biology	2	2	64

Van N. Nguyen

×

15

Publications

1.5K

Citations

15

H-Index

	Year	Citations
Chemical genetics strategy identifies an HCV NS5A inhibitor with a potent clinical effect Min Gao, Richard E. Nettles, Makonen Belema, Nature Hcv Ns5a InhibitorViral HepatitisMedicineAntiviral Drug DevelopmentAntiviral Therapy	2010	929
Amidino benzimidazole inhibitors of bacterial two-component systems Michele A. Weidner‐Wells, Kwasi A. Ohemeng, Van N. Nguyen, Bioorganic & Medicinal Chemistry Letters Amidino Benzimidazole InhibitorsMedicineAntibacterial AgentAntimicrobial ChemotherapyMicrobiology	2001	120
Hepatitis C Virus NS5A Replication Complex Inhibitors: The Discovery of Daclatasvir Makonen Belema, Van N. Nguyen, Carol Bachand, Journal of Medicinal Chemistry	2014	87
Synthesis and Inhibitory Activity of Novel Tri- and Tetracyclic Quinolines against Topoisomerases Zhihua Sui, Jason Altom, Van N. Nguyen, Bioorganic & Medicinal Chemistry Inhibitory ActivityNovel Tri-HeterocyclicBiochemistryMedicine	1998	48
Characterizations of HCV NS5A replication complex inhibitors Donald R. O’Boyle, Jin-Hua Sun, Peter T. Nower, Virology Antiviral Drug DevelopmentMolecular BiologyVirologyAntiviral DrugMedicine	2013	47
Synthesis and 5-Lipoxygenase Inhibitory Activities of Some Novel 2-Substituted 5-Benzofuran Hydroxamic Acids Kwasi A. Ohemeng, Mary A. Appollina, Van N. Nguyen, Journal of Medicinal Chemistry	1994	45
HCV NS5A Replication Complex Inhibitors. Part 4.1 Optimization for Genotype 1a Replicon Inhibitory Activity Denis R. St. Laurent, Michael H. Serrano‐Wu, Makonen Belema, Journal of Medicinal Chemistry Viral ReplicationMolecular BiologyPharmacotherapyAntiviral DrugChemical Biology	2013	35
Synthesis and structure–activity relationship of imidazo(1,2-a)thieno(3,2-e)pyrazines as IKK-β inhibitors Makonen Belema, Amy Bunker, Van N. Nguyen, Bioorganic & Medicinal Chemistry Letters Medicinal ChemistryNatural SciencesMedicinePharmacological AgentChemistry	2007	34
Synthesis and topoisomerase inhibitory activities of novel aza-analogues of flavones11Part of the work was presented at the XIVth International Symposium on Medicinal Chemistry, Maastricht, NL, 1996 (Abst. P–10.17) Zhihua Sui, Van N. Nguyen, Jason Altom, European Journal of Medicinal Chemistry Medicinal ChemistryNatural Product SynthesisBiochemistryNovel Aza-analoguesMedicine	1999	30
HCV NS5A replication complex inhibitors. Part 3 : discovery of potent analogs with distinct core topologies Omar D. Lopez, Van N. Nguyen, Denis R. St. Laurent, Bioorganic & Medicinal Chemistry Letters	2012	29

Page 1